Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

29 Results Found

AHA Preferred Cybersecurity & Risk Provider Program

AHA created a panel of vetted, highly-reputable cybersecurity and risk service providers to support AHA members’ cyber and risk initiatives

ASHE ICRA 2.0™ Toolkit

ASHE ICRA 2.0™ includes several improvements and clarifications to help in prevention planning for construction projects.

Life Safety Risk Assessment Tool

Compliance Tools

Risk Assessment Inventory

This risk assessment tool has been developed to help health care facility staff comply with the risk-based, patient-focused approach described by the 2021 version of NFPA 99: Health Care Facilities Code.

Hazard Vulnerability Assessment (HVA) Tool

Use this HVA tool to assist your multidisciplinary group in assessing and prioritizing exercises for potential hazards/risk.

ASHE Wet Location Tool

Compliance Tools
Public

AHA Response to FEMA RFI on Disaster Responses, Public Assistance Program

AHA's comment on our members’ experiences with the Federal Emergency Management Agency’s (FEMA) disaster responses, in particular the FEMA Public Assistance (PA) program
Public

AHA Comments on DEA Proposed Rule on Special Registrations for Telemedicine Prescribing

AHA comments regarding the Drug Enforcement Administration’s proposed rule for Special Registrations for Telemedicine and Limited State Telemedicine Registrations.
Member

Telemedicine Prescribing of Controlled Substances

The Department of Health and Human Services (HHS) and Drug Enforcement Administration (DEA) Jan. 15 released a proposed rule on special registration for prescribing of controlled substances and a final rule on telemedicine prescribing of buprenorphine.
Member

DEA and HHS Extend Waivers Prescribing Controlled Substances through Telemedicine

The Drug Enforcement Administration (DEA) and Department of Health and Human Services (HHS) on Nov. 15 published a rule to extend waiver flexibilities for prescribing controlled substances via telemedicine.